Clinical Trial Update: Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the immunogenicity and safety of a meningococcal ACWY conjugate vaccine in healthy 2- to 18-year-olds in Taiwan; results completed and p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Meningitis
• Meningococcal Disease

Drugs mentioned

• Meningococcal ACWY Conjugate Vaccine (Meningococcal conjugate vaccine (serogroups A, C, W, Y))

Snippet

Sponsor: Novartis | Conditions: Bacterial Meningitis | Phase 3 | Status: COMPLETED | Results posted: 2014-09-22